Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Marc Frahm is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 01/08/2025 | SANA | Buy Now | Sana Biotechnology | $2.17 | ā | Marc Frahm23% | ā | Upgrade | Hold ā Buy | Get Alert |
| 08/06/2024 | TBPH | Buy Now | Theravance Biopharma | $9.31 | -3.33% | Marc Frahm23% | $10 ā $9 | Maintains | Hold | Get Alert |
| 05/01/2024 | INCY | Buy Now | Incyte | $62.08 | 28.87% | Marc Frahm23% | $88 ā $80 | Maintains | Buy | Get Alert |
| 08/14/2023 | SANA | Buy Now | Sana Biotechnology | $2.17 | ā | Marc Frahm23% | ā | Initiates | ā Market Perform | Get Alert |
| 06/15/2023 | CGEM | Buy Now | Cullinan Oncology | $8.30 | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 05/03/2023 | INCY | Buy Now | Incyte | $62.08 | 49.81% | Marc Frahm23% | $100 ā $93 | Maintains | Outperform | Get Alert |
| 03/01/2023 | DICE | Buy Now | DICE Therapeutics | ā | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 02/08/2023 | INCY | Buy Now | Incyte | $62.08 | 61.08% | Marc Frahm23% | $95 ā $100 | Maintains | Outperform | Get Alert |
| 01/26/2023 | MGTA | Buy Now | Magenta Therapeutics | ā | ā | Marc Frahm23% | ā | Downgrade | Outperform ā Market Perform | Get Alert |
| 11/22/2022 | IMGO | Buy Now | Imago BioSciences | ā | ā | Marc Frahm23% | ā $36 | Downgrade | Outperform ā Market Perform | Get Alert |
| 11/16/2021 | XLO | Buy Now | Xilio Therapeutics | $0.75 | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 08/24/2021 | TBPH | Buy Now | Theravance Biopharma | $9.31 | 50.38% | Marc Frahm23% | $42 ā $14 | Downgrade | Outperform ā Market Perform | Get Alert |
| 08/23/2021 | NUVL | Buy Now | Nuvalent | $74.98 | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 08/10/2021 | IMGO | Buy Now | Imago BioSciences | ā | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 07/20/2021 | ELEV | Buy Now | Elevation Oncology | $0.28 | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 07/06/2021 | JANX | Buy Now | Janux Therapeutics | $30.83 | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 06/21/2021 | DAWN | Buy Now | Day One Biopharmaceutical | $8.00 | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 06/03/2021 | CNST | Buy Now | Constellation | ā | ā | Marc Frahm23% | ā | Downgrade | Outperform ā Market Perform | Get Alert |
| 03/02/2021 | ANGN | Buy Now | Angion Biomedica | ā | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 08/18/2020 | INZY | Buy Now | Inozyme Pharma | $0.96 | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 05/13/2020 | TBPH | Buy Now | Theravance Biopharma | $9.31 | 351.13% | Marc Frahm23% | ā $42 | Initiates | ā Outperform | Get Alert |
| 02/24/2020 | BDTX | Buy Now | Black Diamond Therapeutic | $1.69 | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
| 02/07/2020 | CNST | Buy Now | Constellation | ā | ā | Marc Frahm23% | ā | Initiates | ā Outperform | Get Alert |
